Jupiter Investment Management’s Corcept Therapeutics CORT Stock Holding History

Jupiter Investment Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$13.3M	Buy	788,865 +307,017	+64%	+$4.31M	0.21%	120
2020 Q1	$5.73M	Buy	+481,848	New	+$5.96M	0.11%	152
2019 Q2	–	Sell	-106,790	Closed	-$1.25M	–	359
2019 Q1	$1.25M	Buy	+106,790	New	+$1.33M	0.01%	242
2018 Q3	–	Sell	-502,429	Closed	-$7.9M	–	383
2018 Q2	$7.9M	Buy	502,429 +358,318	+249%	+$6.23M	0.06%	178
2018 Q1	$2.37M	Sell	144,111 -921,416	-86%	-$17.1M	0.02%	231
2017 Q4	$19.2M	Buy	1,065,527 +743,145	+231%	+$13.5M	0.18%	114
2017 Q3	$6.22M	Buy	+322,382	New	+$4.81M	0.07%	162
2016 Q4	–	Sell	-33,426	Closed	-$217K	–	377
2016 Q3	$217K	Buy	+33,426	New	+$194K	﹤0.01%	312

Other funds holding CORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Jupiter Investment Management's CORT Position: Q2 2020 in Review

Jupiter Investment Management increased its Corcept Therapeutics (CORT) stake by 64% in Q2 2020, buying an estimated $4.31M and bringing the position to 788,865 shares worth $13.3M. The position accounts for 0.21% of the portfolio, ranked #120.

Jupiter Investment Management first reported a position in CORT in Q3 2016 and has held it in 8 quarters since. The position peaked at $19.2M in Q4 2017. 224 funds tracked by Wall St. Rank hold CORT as of Q2 2020.

Jupiter Investment Management held 788,865 shares of Corcept Therapeutics worth $13.3M as of Q2 2020.
Jupiter Investment Management bought 307,017 Corcept Therapeutics shares in Q2 2020, an estimated $4.31M.
Corcept Therapeutics made up 0.21% of Jupiter Investment Management's portfolio in Q2 2020, its #120 holding.
Jupiter Investment Management first reported a position in Corcept Therapeutics in Q3 2016 and has held it in 8 quarters since.
Jupiter Investment Management's Corcept Therapeutics position peaked at $19.2M in Q4 2017.
224 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.